Pharmaroth Inventory from 2010 to 2026

ROTH Stock  USD 0.0001  0.00  0.00%   
Pharmaroth Labs' Inventory is increasing with slightly volatile movements from year to year. Inventory is predicted to flatten to about 109 K. For the period between 2010 and 2026, Pharmaroth Labs, Inventory quarterly trend regression had mean deviation of  43,761 and range of 127.8 K. View All Fundamentals
 
Inventory  
First Reported
2010-12-31
Previous Quarter
173 K
Current Value
109 K
Quarterly Volatility
49.5 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Pharmaroth Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharmaroth Labs' main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 154.1 K or Total Revenue of 219.2 K, as well as many indicators such as Price To Sales Ratio of 10.56, Dividend Yield of 0.0 or Days Sales Outstanding of 193. Pharmaroth financial statements analysis is a perfect complement when working with Pharmaroth Labs Valuation or Volatility modules.
  
Build AI portfolio with Pharmaroth Stock
Check out the analysis of Pharmaroth Labs Correlation against competitors.
For more detail on how to invest in Pharmaroth Stock please use our How to Invest in Pharmaroth Labs guide.
The Inventory trend for Pharmaroth Labs offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Pharmaroth Labs is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Pharmaroth Labs' Inventory Growth Pattern

Below is the plot of the Inventory of Pharmaroth Labs over the last few years. It is Pharmaroth Labs' Inventory historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pharmaroth Labs' overall financial position and show how it may be relating to other accounts over time.
Inventory10 Years Trend
Slightly volatile
   Inventory   
       Timeline  

Pharmaroth Inventory Regression Statistics

Arithmetic Mean115,522
Geometric Mean102,123
Coefficient Of Variation42.88
Mean Deviation43,761
Median150,462
Standard Deviation49,535
Sample Variance2.5B
Range127.8K
R-Value0.78
Mean Square Error1B
R-Squared0.61
Significance0.0002
Slope7,674
Total Sum of Squares39.3B

Pharmaroth Inventory History

2026109 K
2025173 K
2016150.5 K
2015101.7 K

Other Fundumenentals of Pharmaroth Labs

Pharmaroth Labs Inventory component correlations

About Pharmaroth Labs Financial Statements

Investors use fundamental indicators, such as Pharmaroth Labs' Inventory, to determine how well the company is positioned to perform in the future. Although Pharmaroth Labs' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Inventory173 K109 K
Change To Inventory-43.9 K-46.1 K
Inventory Turnover 0.83  0.79 
Days Of Inventory On Hand 453.71  476.40 
Average Inventory66.1 K39.3 K
Days Of Inventory Outstanding 453.71  476.40 

Currently Active Assets on Macroaxis

When determining whether Pharmaroth Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pharmaroth Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pharmaroth Labs Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pharmaroth Labs Stock:
Check out the analysis of Pharmaroth Labs Correlation against competitors.
For more detail on how to invest in Pharmaroth Stock please use our How to Invest in Pharmaroth Labs guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is there potential for Biotechnology market expansion? Will Pharmaroth introduce new products? Factors like these will boost the valuation of Pharmaroth Labs. Anticipated expansion of Pharmaroth directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Pharmaroth Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
0.002
The market value of Pharmaroth Labs is measured differently than its book value, which is the value of Pharmaroth that is recorded on the company's balance sheet. Investors also form their own opinion of Pharmaroth Labs' value that differs from its market value or its book value, called intrinsic value, which is Pharmaroth Labs' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Pharmaroth Labs' market value can be influenced by many factors that don't directly affect Pharmaroth Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Pharmaroth Labs' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pharmaroth Labs should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Pharmaroth Labs' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.